In two of the studies [44,51], there was no difference between the tumor spectra of p53R172H/R172H and p53-/- mice, while in the third study [43], p53R172H/- mice developed carcinomas and hemangiosarcomas with increased incidence compared to p53-/- mice. The gene discussed is TP53; the disease is angiosarcoma.